Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice

Marulanda, Kathleen; Mercel, Alexandra; Gillis, David C.; Sun, Kui; Gambarian, Maria; Roark, Joshua; Weiss, Jenna; Tsihlis, Nick D.; Karver, Mark R.; Centeno, S. Ruben; Peters, Erica B.; Clemons, Tristan D.; Stupp, Samuel I.; McLean, Sean E.; Kibbe, Melina R.

doi:10.1002/adhm.202100302

Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice

Journal Article · 01 July 2021 · Adv. Healthcare Mat.

DOI:https://doi.org/10.1002/adhm.202100302· OSTI ID:1818325

Marulanda, Kathleen; Mercel, Alexandra; Gillis, David C.; Sun, Kui; Gambarian, Maria; Roark, Joshua; Weiss, Jenna; Tsihlis, Nick D.; Karver, Mark R.; Centeno, S. Ruben; Peters, Erica B.; Clemons, Tristan D.; Stupp, Samuel I.; McLean, Sean E.; Kibbe, Melina R.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH); UNIVERSITY

OSTI ID:: 1818325

Journal Information:: Adv. Healthcare Mat., Vol. 10, Issue (13)

Country of Publication:: United States

Language:: ENGLISH

References (96)

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives No authors listed European Respiratory Journal https://doi.org/10.1183/13993003.01887-2018		January 2019
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry No authors listed Chest https://doi.org/10.1378/chest.15-0300		October 2015
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension No authors listed Respiratory Medicine https://doi.org/10.1016/j.rmed.2009.07.015		January 2010
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension No authors listed Frontiers in Physiology https://doi.org/10.3389/fphys.2018.00890		July 2018
What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension No authors listed International Journal of Cardiology https://doi.org/10.1016/j.ijcard.2017.04.016		August 2017
Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics No authors listed Future Cardiology https://doi.org/10.2217/fca.13.6		May 2013
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology No authors listed American Heart Journal https://doi.org/10.1016/j.ahj.2007.02.037		June 2007
Principles of nanoparticle design for overcoming biological barriers to drug delivery No authors listed Nature Biotechnology https://doi.org/10.1038/nbt.3330		September 2015
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension No authors listed Journal of Controlled Release https://doi.org/10.1016/j.jconrel.2013.01.011		April 2013
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension No authors listed Journal of Controlled Release https://doi.org/10.1016/j.jconrel.2015.05.261		July 2015
Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling No authors listed Hypertension https://doi.org/10.1161/HYPERTENSIONAHA.118.11932		March 2019
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats No authors listed International Heart Journal https://doi.org/10.1536/ihj.17-683		January 2018
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension No authors listed International Journal of Pharmaceutics https://doi.org/10.1016/j.ijpharm.2017.03.069		May 2017
Encapsulation of beraprost sodium in nanoparticles: Analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension No authors listed Journal of Controlled Release https://doi.org/10.1016/j.jconrel.2014.10.029		January 2015
Shape-Dependent Targeting of Injured Blood Vessels by Peptide Amphiphile Supramolecular Nanostructures No authors listed Small https://doi.org/10.1002/smll.201403429		February 2015
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design No authors listed Nano Letters https://doi.org/10.1021/nl900031y		May 2009
An Assessment of the Effects of Shell Cross-Linked Nanoparticle Size, Core Composition, and Surface PEGylation on in Vivo Biodistribution No authors listed Biomacromolecules https://doi.org/10.1021/bm050260e		September 2005
Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers No authors listed Science https://doi.org/10.1126/science.1063187		November 2001
Tissue-Factor Targeted Peptide Amphiphile Nanofibers as an Injectable Therapy To Control Hemorrhage No authors listed ACS Nano https://doi.org/10.1021/acsnano.5b06025		December 2015
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties No authors listed Progress in Lipid Research https://doi.org/10.1016/S0163-7827(03)00033-X		November 2003
Self-assembled polypeptide-block-poly(vinylpyrrolidone) as prospective drug-delivery systems No authors listed Colloids and Surfaces B: Biointerfaces https://doi.org/10.1016/j.colsurfb.2009.07.032		November 2009
Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury No authors listed Antioxidants & Redox Signaling https://doi.org/10.1089/ars.2015.6363		March 2016
Development of Optimized Tissue-Factor-Targeted Peptide Amphiphile Nanofibers to Slow Noncompressible Torso Hemorrhage No authors listed ACS Nano https://doi.org/10.1021/acsnano.9b09243		May 2020
Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension No authors listed The Journal of Pathology https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q		January 2000
Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. No authors listed Journal of Clinical Investigation https://doi.org/10.1172/JCI118228		October 1995
Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo : antibody targeting to the lung induces ACE antigenic modulation No authors listed International Immunology https://doi.org/10.1093/intimm/6.8.1153		January 1994
All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses No authors listed Paediatric Respiratory Reviews https://doi.org/10.1016/j.prrv.2017.03.012		June 2017
RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension No authors listed Cardiovascular Research https://doi.org/10.1093/cvr/cvx051		April 2017
Angiotensin I-converting enzyme inhibitory peptides from Sipuncula (Phascolosoma esculenta): Purification, identification, molecular docking and antihypertensive effects on spontaneously hypertensive rats No authors listed Process Biochemistry https://doi.org/10.1016/j.procbio.2017.08.009		December 2017
Virtual screening for angiotensin I-converting enzyme inhibitory peptides from Phascolosoma esculenta No authors listed Bioresources and Bioprocessing https://doi.org/10.1186/s40643-014-0017-5		October 2014
Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension. No authors listed Heart https://doi.org/10.1136/hrt.48.6.541		December 1982
Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes No authors listed Cardiovascular Research https://doi.org/10.1016/S0008-6363(03)00470-X		September 2003
Angiotensin-converting Enzyme Inhibition Delays Pulmonary Vascular Neointimal Formation No authors listed American Journal of Respiratory and Critical Care Medicine https://doi.org/10.1164/ajrccm.158.3.9710007		September 1998
Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. No authors listed Heart https://doi.org/10.1136/hrt.48.3.272		September 1982
Captopril in primary pulmonary hypertension. No authors listed Circulation https://doi.org/10.1161/01.CIR.67.1.155		January 1983
Inhibition Mechanism and Model of an Angiotensin I-Converting Enzyme (ACE)-Inhibitory Hexapeptide from Yeast (Saccharomyces cerevisiae) No authors listed PLoS ONE https://doi.org/10.1371/journal.pone.0037077		May 2012
Isolation and Identification of an Angiotensin-I Converting Enzyme Inhibitory Peptide from Yeast (Saccharomyces cerevisiae) No authors listed Current Analytical Chemistry https://doi.org/10.2174/157341112798472224		January 2012
RAGE: a single receptor fits multiple ligands No authors listed Trends in Biochemical Sciences https://doi.org/10.1016/j.tibs.2011.08.008		December 2011
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling No authors listed Structure https://doi.org/10.1016/j.str.2016.06.021		September 2016
Structural Basis for Ligand Recognition and Activation of RAGE No authors listed Structure https://doi.org/10.1016/j.str.2010.05.017		October 2010
The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis No authors listed Journal of Leukocyte Biology https://doi.org/10.1189/jlb.0510262		August 2010
Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury No authors listed European Journal of Pharmaceutical Sciences https://doi.org/10.1016/j.ejps.2017.12.019		March 2018
Is RAGE still a therapeutic target for Alzheimer’s disease? No authors listed Future Medicinal Chemistry https://doi.org/10.4155/fmc.12.51		May 2012
Binding studies of truncated variants of the Aβ peptide to the V-domain of the RAGE receptor reveal Aβ residues responsible for binding No authors listed Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics https://doi.org/10.1016/j.bbapap.2011.02.011		May 2011
Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis No authors listed Macromolecular Bioscience https://doi.org/10.1002/mabi.201900066		May 2019
Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery No authors listed Advanced Healthcare Materials https://doi.org/10.1002/adhm.201801545		January 2019
Peptide Amphiphile Nanostructures for Targeting of Atherosclerotic Plaque and Drug Delivery No authors listed Advanced Biosystems https://doi.org/10.1002/adbi.201700123		February 2018
Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function No authors listed Journal of Applied Physiology https://doi.org/10.1152/japplphysiol.00533.2010		January 2011
Hypoxia Does neither Stimulate Pulmonary Artery Endothelial Cell Proliferation in Mice and Rats with Pulmonary Hypertension and Vascular Remodeling nor in Human Pulmonary Artery Endothelial Cells No authors listed Journal of Vascular Research https://doi.org/10.1159/000327005		January 2011
Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells No authors listed Cell and Tissue Research https://doi.org/10.1007/s00441-005-0069-0		November 2005
Cellular uptake of nanoparticles: journey inside the cell No authors listed Chemical Society Reviews https://doi.org/10.1039/C6CS00636A		January 2017
RAGE and amyloid beta interactions: Atomic force microscopy and molecular modeling No authors listed Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease https://doi.org/10.1016/j.bbadis.2005.03.014		June 2005
Advanced Glycation End Product Recognition by the Receptor for AGEs No authors listed Structure https://doi.org/10.1016/j.str.2011.02.013		May 2011
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles No authors listed International Journal of Nanomedicine https://doi.org/10.2147/IJN.S36111		November 2012
Cell death versus cell survival instructed by supramolecular cohesion of nanostructures No authors listed Nature Communications https://doi.org/10.1038/ncomms4321		February 2014
Biomolecular studies by circular dichroism No authors listed Frontiers in Bioscience https://doi.org/10.2741/3676		January 2011
Programmable Assembly of Peptide Amphiphile via Noncovalent-to-Covalent Bond Conversion No authors listed Journal of the American Chemical Society https://doi.org/10.1021/jacs.7b03878		June 2017
Monodisperse cylindrical micelles by crystallization-driven living self-assembly No authors listed Nature Chemistry https://doi.org/10.1038/nchem.664		May 2010
Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury No authors listed Nanomaterials https://doi.org/10.3390/nano10030420		February 2020
Renal clearance of quantum dots No authors listed Nature Biotechnology https://doi.org/10.1038/nbt1340		September 2007
Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH No authors listed PLoS ONE https://doi.org/10.1371/journal.pone.0106440		September 2014
Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology No authors listed Journal of the American Heart Association https://doi.org/10.1161/JAHA.112.005157		January 2013
Pulmonary Arterial Hypertension No authors listed Circulation https://doi.org/10.1161/CIRCULATIONAHA.104.503540		September 2006
Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms No authors listed Circulation Research https://doi.org/10.1161/01.RES.0000243584.45145.3f		September 2006
RAGE, vascular tone and vascular disease No authors listed Pharmacology & Therapeutics https://doi.org/10.1016/j.pharmthera.2009.06.013		November 2009
RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity No authors listed Human Molecular Genetics https://doi.org/10.1093/hmg/ddy017		January 2018
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response No authors listed Genes & Immunity https://doi.org/10.1038/sj.gene.6363861		May 2002
Blockade of RAGE Suppresses Alloimmune Reactions In Vitro and Delays Allograft Rejection in Murine Heart Transplantation No authors listed American Journal of Transplantation https://doi.org/10.1111/j.1600-6143.2006.01617.x		February 2007
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis No authors listed Clinical Cancer Research https://doi.org/10.1158/1078-0432.CCR-12-0221		June 2012
Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer No authors listed Journal for ImmunoTherapy of Cancer https://doi.org/10.1186/s40425-019-0765-z		October 2019
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions No authors listed Journal of Investigative Dermatology https://doi.org/10.1046/j.0022-202X.2004.22218.x		February 2004
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer No authors listed The Journal of Pathology https://doi.org/10.1002/path.1031		January 2002
The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases No authors listed Mucosal Immunology https://doi.org/10.1038/s41385-018-0119-z		December 2018
Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats No authors listed European Journal of Pharmacology https://doi.org/10.1016/j.ejphar.2014.08.017		October 2014
Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus No authors listed Neurochemical Research https://doi.org/10.1007/s11064-015-1814-8		January 2016
Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis No authors listed Oncogene https://doi.org/10.1038/onc.2016.324		September 2016
Blockade of RAGE ameliorates elastase‐induced emphysema development and progression via RAGE‐DAMP signaling No authors listed The FASEB Journal https://doi.org/10.1096/fj.201601155R		February 2017
Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease No authors listed Neurology https://doi.org/10.1212/WNL.0000000000000364		April 2014
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease No authors listed Alzheimer Disease & Associated Disorders https://doi.org/10.1097/WAD.0b013e318204b550		January 2011
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease No authors listed BMC Neurology https://doi.org/10.1186/1471-2377-14-12		January 2014
Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension No authors listed PLOS ONE https://doi.org/10.1371/journal.pone.0203046		September 2018
Modified-Peptide Inhibitors of Amyloid β-Peptide Polymerization No authors listed Biochemistry https://doi.org/10.1021/bi982824n		May 1999
Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation No authors listed Biochemical and Biophysical Research Communications https://doi.org/10.1006/bbrc.1996.1413		September 1996
Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.272.19.12601		May 1997
Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.271.15.8545		April 1996
Site-Specific Blockade of RAGE-Vd Prevents Amyloid- Oligomer Neurotoxicity No authors listed Journal of Neuroscience https://doi.org/10.1523/JNEUROSCI.4878-07.2008		May 2008
Biocatalytic self-assembly of 2D peptide-based nanostructures No authors listed Soft Matter https://doi.org/10.1039/c1sm05981e		January 2011
Tyrosine-mediated two-dimensional peptide assembly and its role as a bio-inspired catalytic scaffold No authors listed Nature Communications https://doi.org/10.1038/ncomms4665		April 2014
Water-Floating Giant Nanosheets from Helical Peptide Pentamers No authors listed ACS Nano https://doi.org/10.1021/acsnano.6b00646		September 2016
Bioactive molecular sheets from self-assembly of polymerizable peptides No authors listed Chemical Communications https://doi.org/10.1039/b806559d		January 2008
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity No authors listed Particle and Fibre Toxicology https://doi.org/10.1186/1743-8977-9-20		January 2012
Coassembled Cytotoxic and Pegylated Peptide Amphiphiles Form Filamentous Nanostructures with Potent Antitumor Activity in Models of Breast Cancer No authors listed ACS Nano https://doi.org/10.1021/nn302503s		August 2012
Irena : tool suite for modeling and analysis of small-angle scattering No authors listed Journal of Applied Crystallography https://doi.org/10.1107/S0021889809002222		February 2009
Echocardiography allows for analysis of pulmonary arterial flow in mice with congenital diaphragmatic hernia No authors listed Journal of Surgical Research https://doi.org/10.1016/j.jss.2017.06.080		January 2018
A simple method for noninvasive estimation of pulmonary vascular resistance No authors listed Journal of the American College of Cardiology https://doi.org/10.1016/S0735-1097(02)02973-X		March 2003
Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension No authors listed Cardiovascular Ultrasound https://doi.org/10.1186/1476-7120-11-7		February 2013

Similar Records

Intravenous Delivery of Lung‐Targeted Nanofibers for Pulmonary Hypertension in Mice

Journal Article · 2021 · Advanced Healthcare Materials · OSTI ID:1996857

Marulanda, Kathleen; Mercel, Alexandra; Gillis, David C.; +12 more

Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension

Journal Article · 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:7044760

Shih, W J; Cottrill, C M; Coupal, J J; +3 more

PERFUSION LUNG SCINTIGRAPHY IN PRIMARY VASCULAR PULMONARY HYPERTENSION.

Journal Article · 1971 · Fortschr. Geb. Roentgenstr. Nuklearmed. 115: No. 1, 27-33(Jul 1971). · OSTI ID:4744388

Koppenhagen, K; Ernst, H; Paeprer, H; +2 more

Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice

Citation Formats

References (96)

Similar Records

Related Subjects